IBBJDefiance NASDAQ Junior Biotechnology ETF
IBBJ Fund Description
IBBJ tracks a market-cap-weighted index of small-cap biotech and pharmaceutical companies listed on the NASDAQ.
IBBJ Factset Analytics Insight
IBBJ covers companies that are focused on various areas within the biotech or pharmaceuticals space. Included companies are those involved in genomics, DNA technology, genetic engineering, and molecular biology, as well as pharmaceutical manufacturers of prescription or over-the counter drugs. Its emphasis on pharmaceuticals makes IBBJ different from some peer funds and its segment benchmark. The underlying index concentrates its exposure to approximately 200 small-cap stocks that are exclusively listed on the NASDAQ Stock Market. Stocks selected must meet certain size and liquidity requirements. The index is market-cap weighted with 8% single security cap for five securities, and the excess is allocated proportionally across the rest. Index’s rebalance and reconstitution occurs semi-annually.
IBBJ MSCI ESG Analytics Insight
Defiance NASDAQ Junior Biotechnology ETF has an MSCI ESG Fund Rating of BB based on a score of 3.44 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Defiance NASDAQ Junior Biotechnology ETF ranks in the 6th percentile within its peer group and in the 18th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.
IBBJ MSCI FaCS and Factor Box
MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.
IBBJ Summary Data
IBBJ Portfolio Data
IBBJ Index Data
IBBJ Portfolio Management
IBBJ Tax Exposures
IBBJ Fund Structure
IBBJ Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of IBBJ. IBBJ is rated a 4 out of 5.
IBBJ Sector/Industry Breakdown
IBBJ Top 10 Holdings[View All]
IBBJ Economic Development
IBBJ Performance Statistics
IBBJ MSCI ESG Ratings
IBBJ Benchmark Comparison Summary
IBBJ Benchmark Comparison Market Cap Size